PacBio Reveals Commercial Specs; Initial Focus on Long Reads, Short Runs, Low Experiment Cost

While several competing sequencing platforms are focusing on large numbers of reads and low cost per base, PacBio is initially emphasizing the comparatively long read lengths, short run time, low cost per experiment, and different applications that its single-molecule analysis system will provide.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.